Navigation Links
Fellowships for outstanding research in drug use and HIV awarded by IAS and NIDA
Date:7/12/2011

Wednesday July 13, 2011 (Geneva, Switzerland) -- The International AIDS Society (IAS) and the US National Institute on Drug Abuse (NIDA) today announced the recipients of their third annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance scientific understanding of the linkages between drug use and HIV while fostering multinational research.

Young researchers from China and Indonesia will be awarded post-doctoral fellowships to pursue outstanding research in the field. (1) IAS/NIDA research fellowships are awarded to junior scientists for 18 months for post-doctoral training and to well-established HIV researchers for eight months of professional development, both at institutes excelling in research on drug use and HIV.

Presentation of the IAS/NIDA fellowships will take place in a fortnight on Wednesday 20 July 2011 at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention at the Auditorium Parco della Musica in Rome, Italy.

The fellowships ceremony will take place immediately before the Plenary Session (08:45-11:00) where NIDA Director Dr Nora D Volkow will give a keynote presentation Ending HIV Transmission Among Drug Users by 2015.

"The innovative research projects that will be implemented by these talented scientists in different disciplines clinical science, law and public health cover multiple areas of research needed to improve strategies targeting HIV infections related to drug use," said IAS President Dr Elly Katabira.

Drug use is a global problem that brings with it greatly increased risk for HIV infection. Approximately three million of the estimated 15.9 million people aged 15 to 64 who injected drugs in 2008 are living with HIV. A total of 120 countries have reported cases of HIV among people who inject drugs. Injecting drug use represents one of the predominant modes of transmission of HIV in Eastern Europe and Central Asia, where HIV prevalence among people who inject drugs is higher than 40 per cent in some countries. Use of other drugs, such as cocaine and methamphetamine, even without injection, is also associated with increased HIV risk behaviours.

"If you don't treat drug dependency, the likelihood of an individual being infected by HIV becomes higher. We need to treat drug users if we want to treat HIV," said Dr Volkow. "In fact, preventing and treating drug use is treating HIV."

Drug-related HIV/AIDS epidemics have followed the spread of cocaine injecting in Latin America and heroin injecting in Asia in the 1980s and the massive spread of injecting heroin and other opiates in Eastern Europe in the 1990s.

Overall growth in numbers of new HIV infections has slowed in most regions of the world. One exception to this trend, however, is the continued growth in numbers of HIV infections linked to injecting drug use, especially in Eastern Europe, Central Asia and more recently, sub-Saharan Africa.


'/>"/>

Contact: Lindsey Rodger
lindsey.rodger@iasociety.org
International AIDS Society
Source:Eurekalert

Related medicine news :

1. The New York Stem Cell Foundation awards fellowships to 7 innovative stem cell scientists
2. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 12 top young scientists
3. University of Toronto scholars receive prestigious New Directions Fellowships
4. Anti-HIV gel leadership team acknowledged for outstanding achievement in world health
5. Outstanding high school students receive AGA Research Foundation Fellowship Awards
6. Outstanding quality of science at 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) underlines conference goal of translating HIV research into practice
7. AACR recognizes the outstanding achievements of Pier Paolo Pandolfi
8. ABTA names Ryan Salinas outstanding 10 summer medical student fellow
9. Ming T. Tsuang recognized with NARSAD outstanding achievement award for schizophrenia research
10. SWOG names 5 cancer researchers outstanding Young Investigators
11. SNM honors outstanding contributors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Dr. Rassouli, cosmetic dentist in ... is among the most popular cosmetic procedures in dentistry today, but the cost often ... put them at risk of teeth whitening-related damage. For a limited time, Dr. Rassouli ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... to create “Ebola: In Praise of Prevention,” an animated video designed ... English and French translations of the video are being distributed throughout Togo, Liberia, ...
(Date:2/8/2016)... ... 08, 2016 , ... CURE Media Group , the nation’s leading digital ... Myeloma Heroes Awards event , which will annually honor individuals making heroic contributions in ... The MM Heroes Awards nomination process is officially open through February 17 ...
(Date:2/8/2016)... ... ... is famous for gift giving with flowers, chocolates and other tokens of affection meant to ... more than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts - no ... lives they’ve led and the people they’ve touched. , That’s why Give ...
(Date:2/8/2016)... ... 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving the ... has teamed up with Citizens Opposed to Domestic Abuse in support of its efforts ... all those victimized by the fear of violence in their own homes, donations may ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb.8, 2016 Cardiovascular Surgery Devices - ... GlobalData,s Medical Devices sector report, "Cardiovascular Surgery Devices ... overview of Cardiovascular Surgery Devices currently in pipeline ... The report provides comprehensive information on the ... at various stages of development. The report reviews ...
(Date:2/8/2016)... YORK , Feb. 8, 2016  Labvantage ... today announces its first male sexual enhancement product, ... EnduramenT combines proven ethnobotanicals with a patented biomedical ... nitric oxide, the chemical compound responsible for many ... Forgoing the use ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , ... and Medimetriks Pharmaceuticals, Inc. (Medimetriks) today announced that they ... development and commercialization rights for OPA-15406 in the U.S. ... also provides manufacturing rights.  OPA-15406 is a topical, non-steroidal ... atopic dermatitis. --> --> ...
Breaking Medicine Technology: